NCT00211757View on ClinicalTrials.gov

Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Autism
Interventions
DRUG

Divalproex sodium

Study drug.

DRUG

Placebo

Placebo comparator.

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Montefiore Medical Center

OTHER

NCT00211757 - Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism | Biotech Hunter | Biotech Hunter